Infection Control Supplies Market Report 2025

The infection control supplies market size has grown steadily in recent years. It will grow from $45.38 billion in 2024 to $46.99 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to healthcare worker safety concerns, public health awareness campaigns, a rise in antimicrobial products, healthcare facility hygiene standards, and advancements in disinfection techniques.

The infection control supplies market size is expected to see strong growth in the next few years. It will grow to $58.8 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the integration of digital health solutions, focus on environmental sustainability, shift in consumer behavior, continued demand for PPE, and evolving regulations and standards. Major trends in the forecast period include remote monitoring and contact tracing, supply chain resilience and redundancy, infection prevention education and training, antimicrobial surface solutions, and a demand surge for disinfectants and sanitizers.

The increasing prevalence of nosocomial infections is anticipated to drive the growth of the infection control supplies market in the coming years. Nosocomial infections are those acquired while receiving healthcare. Infection control supplies are essential in healthcare settings for preventing the spread of these infections. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Therefore, the rising incidence of nosocomial infections is expected to propel the infection control supplies market forward.

The rise in healthcare expenditure is expected to accelerate the growth of the infection control supplies market in the coming years. Healthcare expenditure refers to the total resources, including financial investments, allocated to healthcare goods and services within a specific timeframe in a given geographical area. As healthcare expenditure increases, healthcare facilities can invest more in infection control measures, thereby enhancing safety and hygiene for both patients and healthcare professionals, which drives demand for infection control supplies. For example, the 2021-2030 National Health Expenditure (NHE) report from the Centers for Medicare & Medicaid Services, a U.S. federal agency, projects that national health spending will grow at an average rate of 5.1% annually from 2021 to 2030, potentially reaching nearly $6.8 trillion. Additionally, Medicare spending is expected to increase at a rate of 7.2% per year, while Medicaid spending is projected to rise at a 5.6% annual rate. Similarly, the Canadian Institute for Health Information, a non-profit organization based in Canada, forecasted total health expenditure to reach $344 billion in 2023, reflecting a modest 2.8% growth compared to the previous year. Thus, the increase in healthcare expenditure is driving the expansion of the infection control supplies market.

Technological advancements in sterilization equipment represent a significant trend in the infection control supplies market. Leading companies in this field are creating innovative solutions, such as sterilizers, to improve the effectiveness and efficiency of sterilization processes. A sterilizer is a device that eradicates all microbial life on instruments using heat, steam, or chemicals, ensuring they are safe for reuse in medical and dental environments. For example, in January 2024, W&H Dentalwerk Burmoos GmbH, an Austria-based dental technology firm, introduced the Lexa Plus sterilizer as a new advancement in infection control. This sterilizer is engineered to optimize the sterilization process, featuring rapid cycle times, intuitive controls, and enhanced monitoring capabilities. This cutting-edge equipment not only guarantees effective sterilization of dental instruments but also includes user-friendly technology that simplifies operation for dental professionals. By enhancing efficiency and safety, the Lexa Plus is designed to address the evolving needs of dental practices while promoting higher standards of infection prevention and patient care.

Major companies in the infection control supplies market are focusing on developing intuitive user interfaces that enable healthcare professionals to easily access tools for monitoring cleanliness and tracking infection rates, thus enhancing patient safety and operational efficiency. Intuitive design entails creating products or interfaces that are user-friendly and straightforward, reducing the need for instructions or prior knowledge. For example, in January 2024, ICP Medical, a U.S.-based infection prevention company, launched a new website aimed at improving user experience while reflecting its mission of "Helping Those Who Help Others." This updated platform consolidates ICP Medical’s infection control products, such as Rapid Refresh quick-change privacy curtains and the BootieButler automatic shoe cover system, offering customers a convenient “one-stop shop.” The website, aligned with TEAM Technologies’ branding, is designed for healthcare, industrial, and government sectors, featuring an accessible layout. Key features include seamless e-commerce capabilities, comprehensive product displays, FAQs, downloadable resources, and engaging instructional videos to facilitate the purchasing process. Additionally, a dedicated page for privacy curtain samples showcases various patterns and styles, highlighting ICP Medical’s commitment to providing accessible and effective infection prevention solutions.

In August 2024, Sowingo, a U.S.-based healthcare technology company, formed a partnership with Germiphene for an undisclosed amount. This collaboration aims to improve infection prevention and control measures in healthcare environments by combining Germiphene's advanced disinfection solutions with Sowingo's inventory management platform. Germiphene, a Canada-based company, specializes in manufacturing cleaning, disinfecting, and sterilization products for a variety of healthcare settings.

Major companies operating in the infection control supplies market include Steris Corporation, Getinge AB, 3M Company, Ecolab Inc., Johnson & Johnson Private Limited, Cardinal Health Inc., Medline Industries LP, Matachana Group, Kimberly-Clark Corporation, Halyard Health, Emergency Medical Products Inc., Certol International LLC, Schülke & Mayr GmbH, Henry Schein Inc., Belimed AG, Sterigenics International LLC, MMM Group, Cantel Medical Corporation, Fortive Corporation, Sotera Health Company, Metrex Research LLC, Reckitt Benckiser Group plc, Pal International, Melag Medizintechnik GmbH & Co. KG, The Miele Group, Systec GmbH, Contec Inc., Diversey Holdings Inc.

North America was the largest region in the infection control supplies market in 2024. The regions covered in the infection control supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection control supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Infection control supplies are tools designed to provide a barrier for the skin, nose, and clothes against infectious agents, aiming to prevent the spread of infections, particularly in healthcare environments.

The primary products within the category of infection control supplies include disinfectants, medical face masks, surgical caps, surgical gowns, and medical gloves. Disinfectants are substances used on non-living objects to kill germs, eliminating microorganisms and preventing infections. These products are distributed through various channels, including wholesalers, retailers, pharmacies, e-commerce, and others. The end-users of infection control supplies encompass hospitals and clinics, medical device companies, pharmaceutical companies, research laboratories, and other relevant entities.

The infection control supplies market research report is one of a series of new reports that provides infection control supplies market statistics, including the infection control supplies industry global market size, regional shares, competitors with an infection control supplies market share, detailed infection control supplies market segments, market trends, and opportunities, and any further data you may need to thrive in the infection control supplies industry. This infection control supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infection control supplies market consists of sales of respirators, infection control apparel, and surgical clippers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.